ArticleDigestive diseases and sciences2025
Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.
An Outtier et al.PubMed ↗Publisher ↗
No numbers read from the abstract.